Mikromol feature product: Bicalutamide- A non-steroidal antiandrogen (NSAA) Kumar Jeetendra | July 4, 2022 Antiandrogens work by blocking the androgen receptor and/or inhibiting or suppressing androgen production. Bicalutamide competes with androgen to bind to androgen receptors, consequently blocking the action of adrenal and testicular androgens that stimulate the growth of normal and malignant prostatic tissue. Introduction: Bicalutamide was first discovered in the 1980s and patented in 1982. It is …
Single Use System: Future of Biopharmaceutical Industries Kumar Jeetendra | July 27, 2022 Single-use systems represent the future in biopharmaceutical processing of therapeutic drugs with significant advantages over traditional reusable stainless-steel systems and partly disposable systems. Introduction: Biopharmaceuticals include a wide range of products, such as vaccines, therapeutic proteins, blood and blood components, and tissues. In contrast to small molecule chemically synthesized drugs, which have a well-defined structure, …
